查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲新生儿筛检市场预测至 2030 年 - 区域分析 - 按产品类型（试剂和检测试剂盒及仪器）、技术、测试类型和最终用户（医院和诊所以及诊断实验室）
市场调查报告书
商品编码
1463688

欧洲新生儿筛检市场预测至 2030 年 - 区域分析 - 按产品类型（试剂和检测试剂盒及仪器）、技术、测试类型和最终用户（医院和诊所以及诊断实验室）

Europe Newborn Screening Market Forecast to 2030 - Regional Analysis - by Product Type (Reagents and Assay Kits, and Instruments), Technology, Test Type, and End User (Hospitals and Clinics, and Diagnostic Laboratories)
出版日期: | 出版商: The Insight Partners | 英文 108 Pages | 订单完成后即时交付

价格

2022年欧洲新生儿筛检市场价值为3.2804亿美元，预计到2030年将达到6.5383亿美元；预计 2022 年至 2030 年复合CAGR为 9.0%。

先天性疾病负担的增加推动了欧洲新生儿筛检市场的发展。

如果不及早发现和治疗，先天性疾病可能会导致终生健康挑战。这些疾病可能导致长期残疾，严重影响家庭、个人、医疗保健系统和社会。世界卫生组织估计，全世界每年有 24 万名新生儿在出生后 28 天内死于这些疾病。另有 17 万名 1 个月至 5 岁儿童因先天性疾病死亡。对许多先天性疾病的遗传基础的日益了解是导致这些疾病负担日益增加的几个因素之一。基因组学和基因检测的进步使医疗保健提供者能够识别新生儿更广泛的基因突变和病症。这种扩展的知识凸显了透过新生儿筛检进行早期诊断以及时采取干预和治疗的重要性。

母亲年龄、环境暴露和生活习惯改变等人口统计的变化会增加新生儿先天性疾病的风险。此外，由于全球人口迅速增长，每天的出生人数不断增加，导致患有先天性疾病风险的婴儿数量不断增加。此外，医疗保健系统和政策制定者认识到早期疾病检测的长期好处。他们越来越多地将新生儿筛检纳入常规医疗保健方案和保险范围，进一步刺激市场成长。先天性疾病负担的增加是新生儿筛检市场成长的重要动力。

欧洲新生儿筛检市场概况

欧洲新生儿筛检市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。欧洲新生儿筛检市场的成长是由医疗保健支出增加以及先天性疾病、新生儿疾病和其他新生儿疾病发病率激增所推动的。医学研究技术的发展以及用于早期发现疾病的多种诊断筛检程序也使欧洲市场受益。随着政府和非政府组织正在製定加强母婴保育的措施，整个地区的新生儿筛检计画数量预计将迅速增加。根据 NCBI 2022 年的信息，预计筛检每年将使欧盟约 4,000 名儿童受益。创新诊断方法（例如 MS/MS 和分子技术）、治疗选择（例如基因疗法和酶替代疗法）的发展以及对罕见疾病的了解的加深正在推动新生儿筛检计画的扩展。

欧洲国家的医疗保健提供者正在提供全面的新生儿筛检小组，涵盖更广泛的遗传和代谢状况。几个欧洲国家的医疗保健当局实施了强制性新生儿筛检计划，确保每个新生儿在出生后不久就接受必要的筛检。根据 NCBI 2023 年发布的资料，脊髓性肌肉萎缩症和严重联合免疫缺陷 (SCID) 筛检都在快速发展；挪威、德国和其他欧洲国家计划从 2021 年和 2022 年起将 SMA 筛检纳入其国家筛检计画。许多其他国家已经开始实施区域试点计画。 SCID 筛检刚刚在捷克共和国启动。这种立法支持增加了筛检测试的总量，并为筛检服务提供者创造了一个稳定且可预测的市场。

欧洲新生儿筛检市场收入及 2030 年预测（百万美元）

欧洲新生儿筛检市场细分

欧洲新生儿筛检市场根据产品类型、技术、测试类型、最终用户和国家进行细分。

根据产品类型，欧洲新生儿筛检市场分为试剂、检测试剂盒和仪器。到 2022 年，试剂和检测试剂盒细分市场将占据更大的欧洲新生儿筛检市场份额。仪器部分细分为新生儿疾病筛检仪器、脉搏血氧仪、新生儿听力筛检仪器和其他仪器。

从技术面来看，欧洲新生儿筛检市场分为串联质谱（TMS）、分子检测、免疫检测和酵素检测、脉搏血氧筛检技术等技术。 2022 年，脉搏血氧仪筛检技术领域占据欧洲最大的新生儿筛检市场。

根据测试类型，欧洲新生儿筛检市场分为干血斑测试、听力筛检测试、危重先天性心臟病（CCHD）测试和其他测试类型。 2022 年，干血斑检测领域占据欧洲最大的新生儿筛检市场。

依最终用户划分，欧洲新生儿筛检市场分为医院、诊所和诊断实验室。到 2022 年，医院和诊所细分市场将占据更大的欧洲新生儿筛检市场。

按国家/地区划分，欧洲新生儿筛检市场分为英国、德国、法国、义大利、西班牙和欧洲其他地区。 2022年，法国在欧洲新生儿筛检市场占据主导地位。

Bio-Rad Laboratories Inc、Masimo Corp、Medtronic Plc、MRC Holland BV、Natus Medical Inc、PerkinElmer Inc、Waters Corp 和 Zentech SA 是欧洲新生儿筛检市场上的一些领先公司。

目录

表中的内容

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲新生儿筛检市场 - 主要产业动态

  • 主要市场驱动因素
    • 政府为新生儿筛检提供的资金激增
    • 先天性疾病负担不断增加
    • 新生儿疾病盛行率不断增加
  • 主要市场限制
    • 新生儿筛检政策和实践缺乏统一
  • 主要市场机会
    • 新生儿基因筛检
  • 未来的趋势
    • 机器学习和人工智慧在筛检中的整合
  • 影响分析：

第 5 章：新生儿筛检市场 - 欧洲市场分析

  • 欧洲新生儿筛检市场收入，2022 - 2030

第 6 章：欧洲新生儿筛检市场 - 2030 年收入和预测 - 按产品类型

  • 概述
  • 2022 年和 2030 年欧洲新生儿筛检市场收入份额（按产品类型划分）
  • 试剂和检测试剂盒
  • 仪器

第 7 章：欧洲新生儿筛检市场 - 收入和 2030 年预测 - 按技术分类

  • 概述
  • 2022 年和 2030 年欧洲新生儿筛检市场收入份额（按技术划分）
  • 串联质谱 (TMS)
  • 分子检测
  • 免疫测定和酵素测定
  • 脉搏血氧筛检技术
  • 其他技术

第 8 章：欧洲新生儿筛检市场 - 2030 年收入和预测 - 按测试类型

  • 概述
  • 2022 年和 2030 年欧洲新生儿筛检市场收入份额，按测试类型划分 (%)
  • 干血斑测试
  • 听力筛检测试
  • 严重先天性心臟病 (CCHD) 测试
  • 其他测试类型

第 9 章：欧洲新生儿筛检市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年欧洲新生儿筛检市场收入份额（按最终用户划分）（%）
  • 医院和诊所
  • 诊断实验室

第 10 章：欧洲新生儿筛检市场 - 国家分析

  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区

第 11 章：欧洲新生儿筛检市场-产业格局

  • 概述
  • 新生儿筛检市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Zentech SA
  • PerkinElmer Inc
  • Waters Corp
  • Bio-Rad Laboratories Inc
  • Masimo Corp
  • Natus Medical Inc.
  • MRC Holland BV
  • Medtronic Plc

第 13 章：附录

Product Code: BMIRE00029604

The Europe newborn screening market was valued at US$ 328.04 million in 2022 and is expected to reach US$ 653.83 million by 2030; it is estimated to grow at a CAGR of 9.0% from 2022 to 2030.

Rising Burden of Congenital Diseases Fuels the Europe Newborn Screening Market.

Congenital diseases can lead to lifelong health challenges if not detected and managed early. These diseases can contribute to long-term disability, significantly affecting families, individuals, healthcare systems, and societies. The WHO estimates that 240,000 newborns worldwide succumb to death each year within 28 days of birth due to these diseases. An additional 170,000 children die between the age of 1 month and 5 years due to congenital diseases. A growing understanding of the genetic basis of many congenital diseases is one of the several factors contributing to the increasing burden of these conditions. Advancements in genomics and genetic testing have enabled healthcare providers to identify a broader range of genetic mutations and conditions in newborns. This expanded knowledge has highlighted the importance of early diagnosis through newborn screening to initiate timely interventions and treatments.

Changing demographics such as maternal age, environmental exposures, and altering lifestyle habits increase the risk of congenital conditions in newborns. Moreover, the number of births occurring every day is on the rise due to the burgeoning global population, resulting in an expanding pool of infants that can be at risk of congenital diseases. In addition, healthcare systems and policymakers recognize the long-term benefits of early disease detection. They increasingly incorporate newborn screening into routine healthcare protocols and insurance coverage, further stimulating market growth. The rising burden of congenital diseases is a significant driver behind the growth of the newborn screening market.

Europe Newborn Screening Market Overview

The European newborn screening market is segmented into Germany, the UK, France, Italy, Spain , and the Rest of Europe. Growth of the newborn screening market in Europe is driven by increased healthcare spending and an upsurge in the occurrence of congenital diseases, neonatal diseases, and other newborn diseases. Developments in techniques employed in medical research and several diagnostic screening procedures for the early detection of illnesses are also benefiting the market in Europe. The number of newborn screening programs across the region is expected to increase rapidly as government and nongovernment organizations are developing measures to enhance mother-childcare. According to information by NCBI in 2022, screening is anticipated to benefit ~4,000 children annually in the EU. The development of innovative diagnostic methods (such as MS/MS and molecular technologies), therapeutic options (such as gene therapy and enzyme replacement therapies), and increased understanding of rare diseases are driving the expansion of newborn screening programs.

Healthcare providers in European countries are offering comprehensive newborn screening panels, encompassing a broader spectrum of genetic and metabolic conditions. Healthcare authorities in several European countries have implemented mandatory newborn screening programs, ensuring every newborn undergoes essential screenings shortly after birth. As per a data published by NCBI in 2023, both spinal muscular atrophy and severe combined immunodeficiency (SCID) screening are evolving quickly; Norway, Germany, and other European countries had plans to include SMA screening in their national screening programs from 2021 and 2022 onward. Regional pilot programs are already underway in many other nations. SCID screening was just launched in the Czech Republic. This legislative support has increased the overall volume of screening tests and created a stable and predictable market for screening service providers.

Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Million)

Europe Newborn Screening Market Segmentation

The Europe newborn screening market is segmented based on product type, technology, test type, end user, and country.

Based on product type, the Europe newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held a larger Europe newborn screening market share in 2022. The reagents and assay kits segment is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.

In terms of technology, the Europe newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held the largest Europe newborn screening market share in 2022.

Based on test type, the Europe newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held the largest Europe newborn screening market share in 2022.

By end user, the Europe newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held a larger Europe newborn screening market share in 2022.

By country, the Europe newborn screening market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. France dominated the Europe newborn screening market in 2022.

Bio-Rad Laboratories Inc, Masimo Corp, Medtronic Plc, MRC Holland BV, Natus Medical Inc, PerkinElmer Inc, Waters Corp, and Zentech SA are some of the leading companies operating in the Europe newborn screening market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Newborn Screening Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Surging Government Funding for Newborn Screening
    • 4.1.2 Rising Burden of Congenital Diseases
    • 4.1.3 Increasing Prevalence of Newborn Disorders
  • 4.2 Key Market Restraints
    • 4.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
  • 4.3 Key Market Opportunities
    • 4.3.1 Genetic Screening of Newborns
  • 4.4 Future Trends
    • 4.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
  • 4.5 Impact Analysis:

5. Newborn Screening Market - Europe Market Analysis

  • 5.1 Europe Newborn Screening Market Revenue (US$ Mn), 2022 - 2030

6. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

  • 6.1 Overview
  • 6.2 Europe Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • 6.3 Reagents and Assay Kits
    • 6.3.1 Overview
    • 6.3.2 Reagents and Assay Kits: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Europe Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
  • 6.4 Instruments
    • 6.4.1 Overview
    • 6.4.2 Instruments: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 Europe Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)

7. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

  • 7.1 Overview
  • 7.2 Europe Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • 7.3 Tandem Mass Spectrometry (TMS)
    • 7.3.1 Overview
    • 7.3.2 Tandem Mass Spectrometry (TMS): Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Molecular Assays
    • 7.4.1 Overview
    • 7.4.2 Molecular Assays: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunoassays and Enzymatic Assays
    • 7.5.1 Overview
    • 7.5.2 Immunoassays and Enzymatic Assays: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pulse Oximetry Screening Technology
    • 7.6.1 Overview
    • 7.6.2 Pulse Oximetry Screening Technology: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Technologies
    • 7.7.1 Overview
    • 7.7.2 Other Technologies: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

  • 8.1 Overview
  • 8.2 Europe Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 8.3 Dry Blood Spot Test
    • 8.3.1 Overview
    • 8.3.2 Dry Blood Spot Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Hearing Screen Test
    • 8.4.1 Overview
    • 8.4.2 Hearing Screen Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Critical Congenital Heart Diseases (CCHD) Test
    • 8.5.1 Overview
    • 8.5.2 Critical Congenital Heart Diseases (CCHD) Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Other Test Types
    • 8.6.1 Overview
    • 8.6.2 Other Test Types: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Europe Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Newborn Screening Market - Country Analysis

  • 10.1 Europe Newborn Screening Market
    • 10.1.1 Europe Newborn Screening Market, by Country
      • 10.1.1.1 UK
        • 10.1.1.1.1 UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.1.2 UK: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.2.1 UK: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.2.2 UK: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.3 UK: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.1.4 UK: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.1.5 UK: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.2 Germany
        • 10.1.1.2.1 Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 Germany: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2.1 Germany: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2.2 Germany: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Germany: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Germany: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.5 Germany: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.3 France
        • 10.1.1.3.1 France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 France: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.2.1 France: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.2.2 France: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.3 France: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.3.4 France: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.3.5 France: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.4 Italy
        • 10.1.1.4.1 Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.2 Italy: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.4.2.1 Italy: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.4.2.2 Italy: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.4.3 Italy: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.4.4 Italy: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.4.5 Italy: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.5 Spain
        • 10.1.1.5.1 Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.5.2 Spain: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.5.2.1 Spain: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.5.2.2 Spain: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.5.3 Spain: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.5.4 Spain: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.5.5 Spain: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.6 Rest of Europe
        • 10.1.1.6.1 Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.6.2 Rest of Europe: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.6.2.1 Rest of Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.6.2.2 Rest of Europe: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.6.4 Rest of Europe: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.6.5 Rest of Europe: Newborn Screening Market, by End User, 2020-2030 (US$ Million)

11. Europe Newborn Screening Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Newborn Screening Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Zentech SA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 PerkinElmer Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Waters Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Bio-Rad Laboratories Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Masimo Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Natus Medical Inc.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 MRC Holland BV
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Medtronic Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Newborn Screening Market Segmentation
  • Table 2. Europe Newborn Screening Market, by Reagents and Assay Kits - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Europe Newborn Screening Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. UK Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. UK Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. UK Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. UK Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. UK Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. UK Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Germany Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Germany Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Germany Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Germany Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Germany Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Germany Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. France Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. France Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. France Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. France Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. France Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. France Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Italy Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Italy Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Italy Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Italy Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Italy Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Italy Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Spain Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Spain Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Spain Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Spain Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Spain Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Spain Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Rest of Europe Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Rest of Europe Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Rest of Europe Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Rest of Europe Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Rest of Europe Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Rest of Europe Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Recent Organic Growth Strategies in Newborn Screening Market
  • Table 41. Recent Inorganic Growth Strategies in the Newborn Screening Market
  • Table 42. Glossary of Terms, Newborn Screening Market

List Of Figures

  • Figure 1. Europe Newborn Screening Market Segmentation, By Country
  • Figure 2. Europe Newborn Screening Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Newborn Screening Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Europe Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 6. Reagents and Assay Kits: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Instruments: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Europe Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 9. Tandem Mass Spectrometry (TMS): Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Molecular Assays: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Immunoassays and Enzymatic Assays: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Pulse Oximetry Screening Technology: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Other Technologies: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Europe Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 15. Dry Blood Spot Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hearing Screen Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Critical Congenital Heart Diseases (CCHD) Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Other Test Types: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Europe Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 20. Hospitals and Clinics: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Diagnostic Laboratories: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Europe Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 23. Europe Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Growth Strategies in Newborn Screening Market